Kane Biotech Inc (TSXV:KNE)
C$ 0.13 0 (0%) Market Cap: 17.23 Mil Enterprise Value: 18.60 Mil PE Ratio: 4.33 PB Ratio: 0 GF Score: 37/100

Kane Biotech Inc Annual Shareholders Meeting Transcript

May 25, 2022 / 09:00PM GMT
Release Date Price: C$0.09
Mark Nawacki
Kane Biotech Inc. - Board Chair, Director

-- come to order. My name is Mark Nawacki, Chair of the corporation. In this annual and special meeting of the shareholders of Kane Biotech Inc., pursuant to the bylaws of the corporation, I will act as Chair of the meeting, and Ray Dupuis will act as secretary of the meeting. I appoint Zabrina Evangelista of TSX Trust Company as scrutineer.

The notice calling this meeting of shareholders was mailed to all the shareholders of record on April 19, 2022. The secretary will annex the declaration as to such mailing to the minutes of the meeting. The scrutineer has provided me with the report on attendance, and it is as follows: we are pleased to report that there are 16 shareholders holding 51,152,853 common shares represented in person or by proxy at this meeting. This represents 44.55% of the 114,830,202 issued and outstanding common shares. I hereby adopt the scrutineer's report.

Notice having been mailed in accordance with the bylaws and applicable policies, and the quorum being present, I declare that this meeting is duly

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot